TAPAS - a long-term non-interventional study evaluating MCT (MicroCrystalline Tyrosine)-associated allergoids shows non-inferiority of clinical effectiveness in children compared to adults during a 3-year course of allergen immunotherapy
Michael Gerstlauer, Jennifer Raab, Silke Allekotte, Laura Day, Christian Neuhof, Verena Johann, Hacer Sahin, Nafi Karahan, Katrin Birkholz, Selda Ugur, Frederik M. Mueller, Matthias F. Kramer, Ralph Mösges; Session L-TPS05 – Allergen immunotherapy 6; EAACI 2024 Congress.